Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017

References

• Mitsumoto H. Amyotrophic lateral sclerosis. Philadelphia (PA): FA Davis Company; 1998.
   Google Scholar
• Bello-Haas VD. Physical therapy for individuals with amyotrophic lateral sclerosis: current insights. Degener Neurol Neuromuscul Dis. 2018;8:45–54.
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9:617–28.
   PubMed Web of Science ®Google Scholar
• Talbott EO, Malek AM, Lacomis D. The epidemiology of amyotrophic lateral sclerosis. Handb Clin Neurol. 2016;138:225–38.
   PubMedGoogle Scholar
• Mehta P, Antao V, Kaye W, Sanchez M, Williamson D, Bryan L, Centers for Disease Control and Prevention (CDC), et al. Prevalence of amyotrophic lateral sclerosis – United States. MMWR Suppl. 2014;63:1–2011.
   PubMedGoogle Scholar
• Mehta P, Kaye W, Bryan L, Larson T, Copeland T, Wu J, et al. Prevalence of amyotrophic lateral sclerosis – United States, 2012–2013. MMWR Surveill Summ. 2016;65:1–12.
   PubMed Web of Science ®Google Scholar
• Mehta P, Kaye W, Raymond J, Punjani R, Larson T, Cohen J, et al. Prevalence of ayotrophic lateral sclerosis – United States, 2015. MMWR Morb Mortal Wkly Rep. 2018;67:1285–9.
   PubMed Web of Science ®Google Scholar
• Mehta P, Kaye W, Raymond J, Wu R, Larson T, Punjani R, et al. Prevalence of amyotrophic lateral sclerosis – United States, 2014. MMWR Morb Mortal Wkly Rep. 2018;67:216–8.
   PubMed Web of Science ®Google Scholar
• Mehta P, Raymond J, Punjani R, Larson T, Bove F, Kaye W, et al. Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016. Amyotroph Lateral Scler Frontotemporal Degener. 2021;0:1–6.
   PubMedGoogle Scholar
• Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology 2009;72:1640–5.
   PubMed Web of Science ®Google Scholar
• Bhandari R, Kuhad A, Kuhad A. Edaravone: a new hope for deadly amyotrophic lateral sclerosis. Drugs Today (Barc). 2018;54:349–60.
   PubMed Web of Science ®Google Scholar
• Dharmadasa T, Kiernan MC. Riluzole, disease stage and survival in ALS. Lancet Neurol. 2018;17:385–6.
   PubMed Web of Science ®Google Scholar
• Andrew AS, Chen CY, Caller TA, Tandan R, Henegan PL, Jackson BP, et al. Toenail mercury levels are associated with amyotrophic lateral sclerosis risk. Muscle Nerve. 2018;58:36–41.
   Web of Science ®Google Scholar
• Bradley WG, Borenstein AR, Nelson LM, Codd GA, Rosen BH, Stommel EW, et al. Is exposure to cyanobacteria an environmental risk factor for amyotrophic lateral sclerosis and other neurodegenerative diseases? Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:325–33.
   PubMed Web of Science ®Google Scholar
• Capozzella A, Sacco C, Chighine A, Loreti B, Scala B, Casale T, et al. Work related etiology of amyotrophic lateral sclerosis (ALS): a meta-analysis. Ann Ig. 2014;26:456–72.
   PubMedGoogle Scholar
• Cox PA, Richer R, Metcalf JS, Banack SA, Codd GA, Bradley WG. Cyanobacteria and BMAA exposure from desert dust: a possible link to sporadic ALS among Gulf War veterans. Amyotroph Lateral Scler. 2009;10(Suppl 2):109–17.
   PubMedGoogle Scholar
• Goutman SA, Boss J, Patterson A, Mukherjee B, Batterman S, Feldman EL. High plasma concentrations of organic pollutants negatively impact survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019;90:907–12.
   PubMed Web of Science ®Google Scholar
• Weisskopf MG, Cudkowicz ME, Johnson N. Military service and amyotrophic lateral sclerosis in a population-based cohort. Epidemiology 2015;26:831–8.
   PubMed Web of Science ®Google Scholar
• Bozzoni V, Pansarasa O, Diamanti L, Nosari G, Cereda C, Ceroni M. Amyotrophic lateral sclerosis and environmental factors. Funct Neurol. 2016;31:7–19.
   PubMed Web of Science ®Google Scholar
• Eisen A. Amyotrophic lateral sclerosis is a multifactorial disease. Muscle Nerve. 1995;18:741–52.
   PubMed Web of Science ®Google Scholar
• Su FC, Goutman SA, Chernyak S, Mukherjee B, Callaghan BC, Batterman S, et al. Association of environmental toxins with amyotrophic lateral sclerosis. JAMA Neurol. 2016;73:803–11.
   PubMed Web of Science ®Google Scholar
• US Public Health Service. ALS Registry Act. Washington, DC: 110th Congress; 2008.
   Google Scholar
• Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System, Weekly Tables of Infectious Disease Data. Atlanta, GA. Available from: https://www.cdc.gov/nndss/infectious-tables.html.
   Google Scholar
• Massachusetts Department of Public Health. Massachusetts ALS Registry. Available from: https://www.mass.gov/als-registry.
   Google Scholar
• Kaye WE, Sanchez M, Wu J. Feasibility of creating a National ALS Registry using administrative data in the United States. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:433–9.
   PubMed Web of Science ®Google Scholar
• U.S. Census Bureau. National Population by Characteristics: 2010–2019. Available from: https://www.census.gov/data/tables/time-series/demo/popest/2010s-national-detail.html.
   Google Scholar
• Hook EB, Regal RR. The value of capture–recapture methods even for apparent exhaustive surveys. The need for adjustment for source of ascertainment intersection in attempted complete prevalence studies. Am J Epidemiol. 1992;135:1060–7.
   PubMed Web of Science ®Google Scholar
• Zhou S, Qian S, Li X, Zheng L, Chang W, Wang L. Using the capture-recapture method to estimate the incidence of amyotrophic lateral sclerosis in Beijing, China. Neuroepidemiology 2018;50:29–34.
   PubMed Web of Science ®Google Scholar
• Huisman MH, de Jong SW, van Doormaal PT, Weinreich SS, Schelhaas HJ, van der Kooi AJ, et al. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry. 2011;82:1165–70.
   PubMed Web of Science ®Google Scholar
• Rosenbohm A, Peter RS, Erhardt S, Lulé D, Rothenbacher D, Ludolph AC, ALS Registry Study Group, et al. Epidemiology of amyotrophic lateral sclerosis in Southern Germany. J Neurol. 2017;264:749–57.
   PubMed Web of Science ®Google Scholar
• Nelson LM, Topol B, Kaye W, Raymond J, Horton DK, Mehta P, et al. Evaluation of the completeness of ALS Case Ascertainment in the U.S. National ALS Registry: application of the capture-recapture method. Neuroepidemiology 2021;0:1–11.
   Google Scholar
• Medicare Resources. Understanding your Medicare Plan Options. Accessed November 12, 2020. Available from: https://www.medicareresources.org/medicare-benefits.
   Google Scholar
• ALS Association. VA Provides Benefits to Veterans with ALS and Families. Accessed November 12, 2020. Available from: http://web.alsa.org/site/PageServer?pagename=va_provides_benefits.
   Google Scholar
• Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res. 2009;65:591–8.
   PubMed Web of Science ®Google Scholar
• King M, Bearman P. Diagnostic change and the increased prevalence of autism. Int J Epidemiol. 2009;38:1224–34.
   PubMed Web of Science ®Google Scholar
• Kaye WE, Wagner L, Wu R, Mehta P. Evaluating the completeness of the national ALS registry, United States. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:112–7.
   PubMed Web of Science ®Google Scholar
• Horton DK, Graham S, Punjani R, Wilt G, Kaye W, Maginnis K, et al. A spatial analysis of amyotrophic lateral sclerosis (ALS) cases in the United States and their proximity to multidisciplinary ALS clinics, 2013. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:126–33.
   PubMed Web of Science ®Google Scholar
• Hogden A, Foley G, Henderson RD, James N, Aoun SM. Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach. J Multidiscip Healthc. 2017;10:205–15.
   PubMed Web of Science ®Google Scholar
• Majmudar S, Wu J, Paganoni S. Rehabilitation in amyotrophic lateral sclerosis: why it matters. Muscle Nerve. 2014;50:4–13.
   PubMed Web of Science ®Google Scholar
• Soriani MH, Desnuelle C. Care management in amyotrophic lateral sclerosis. Rev Neurol (Paris). 2017;173:288–99.
   PubMed Web of Science ®Google Scholar
• Insurance Information Institute. Facts + Statistics: Industry Overview. Available from: https://www.iii.org/fact-statistic/facts-statistics-industry-overview.
   Google Scholar
• ALS Association. FYI: A Professional’s Guide to Assisting Families with Obtaining Government Benefits. Available from: https://www.als.org/navigating-als/resources/fyi-professionals-guide-assisting-families-obtaining-government-benefits.
   Google Scholar
• IQVIA Human Data Science. IQVIA PharMetrics Plus. Accessed November 12, 2020. Available from: https://www.iqvia.com.
   Google Scholar
• Optum Health Services Innovation Company. Accessed November 12, 2020. Available from: https://www.optum.com.
   Google Scholar
• Truven Marketscan Research Data. Accessed November 12, 2020. Available from: https://marketscan.truvenhealth.com/marketscanportal/.
   Google Scholar
• Irish Motor Neurone Disease Register. Available from: https://www.hiqa.ie/areas-we-work/health-information/data-collections/irish-motor-neurone-disease-register.
   Google Scholar
• Gomeni R, Fava M, Pooled Resource Open-Access ALS Clinical Trials Consortium. Pooled Resource Open-Access ALSCTC. Amyotrophic lateral sclerosis disease progression model. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:119–29.
   PubMed Web of Science ®Google Scholar
• Huang F, Zhu Y, Hsiao-Nakamoto J, Tang X, Dugas JC, Moscovitch-Lopatin M, et al. Longitudinal biomarkers in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2020;7:1103–16.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. HIV Surveillance Report. Accessed November 12, 2020. Available from: https://www.cdc.gov/hiv/statistics/overview/index.html.
   Google Scholar
• Yelk Woodruff RS, Pratt RH, Armstrong LR. The US National Tuberculosis Surveillance System: a descriptive assessment of the completeness and consistency of data reported from 2008 to 2012. JMIR Public Health Surveill. 2015;1:e15.
   PubMedGoogle Scholar